Table 1 Associated factors of AKI in patients with hematologic malignancies

  < 29 yr

2.16 (1.47~3.18)

 30~49 yr

1.00

 50~69 yr

0.96 (0.72~1.28)

  ≥ 70 yr

1.08 (0.76~1.55)

 Male

1.00

 Female

1.44 (1.16~1.80)

 Hypertension

1.04 (0.79~1.37)

 Diabetes

1.58 (1.26~1.98)

 Lymphoma

1.00

 Leukemia

2.02 (1.42~2.86)

 Multiple Myeloma

2.05 (1.49~2.81)

 Emergent

1.94 (1.34~2.82)

 Normal

1.00

 ASCT

4.37 (2.04~9.36)

 Chemotherapy

2.24 (1.57~3.79)

 Untreated/palliative

1.00

 ALT (≥40 U/L)

1.74 (1.17~2.58)

 AST (≥35 U/L)

1.76 (1.29~2.39)

 TBiL(≥20.4 μmol/L)

1.29 (0.75~2.21)

 SCr(≥115 μmol/L)

15.9 (10.44~24.21)

 eGFR(≥90 mL/min/1.73m²)

1.00

 eGFR(60~89 mL/min/1.73m²)

1.96 (1.51~2.55)

 eGFR(≤59 mL/min/1.73m²)

13.75 (9.52~19.86)

 SUA(≤359 μmol/L)

1.00

 SUA (360~420 μmol/L)

1.22 (0.89~1.68)

 SUA (421~480 μmol/L)

1.79 (1.23~2.62)

 SUA (≥481 μmol/L)

5.11 (3.66~7.13)

 Album (< 35 g/L)

2.72 (2.16~3.43)

 Hemoglobin (< 115 g/L)

3.85 (2.93~5.04)

 WBC (≥9.5 × 10⁹)

2.15 (1.66~2.79)

 Hyponatremia

5.84 (4.50~7.59)

 Hypernatremia

4.74 (2.47~9.09)

 Hypokalemia

4.59 (3.53~5.97)

 Hyperkalemia

39.69 (13.45~117.15)